1. Home
  2. TGE vs EDSA Comparison

TGE vs EDSA Comparison

Compare TGE & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TGE

The Generation Essentials Group Class A Ordinary Shares

N/A

Current Price

$0.91

Market Cap

50.9M

ML Signal

N/A

Logo Edesa Biotech Inc.

EDSA

Edesa Biotech Inc.

HOLD

Current Price

$5.35

Market Cap

51.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TGE
EDSA
Founded
2023
2015
Country
France
Canada
Employees
166
N/A
Industry
Newspapers/Magazines
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
50.9M
51.6M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
TGE
EDSA
Price
$0.91
$5.35
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$5.00
AVG Volume (30 Days)
35.5K
49.2K
Earning Date
04-29-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$2.99
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.78
$0.72
52 Week High
$4.40
$20.32

Technical Indicators

Market Signals
Indicator
TGE
EDSA
Relative Strength Index (RSI) 44.79 45.73
Support Level $0.91 $4.80
Resistance Level $1.22 $5.82
Average True Range (ATR) 0.07 0.54
MACD 0.00 0.11
Stochastic Oscillator 44.14 75.18

Price Performance

Historical Comparison
TGE
EDSA

About TGE The Generation Essentials Group Class A Ordinary Shares

The Generation Essentials Group is a media and entertainment company. Its publications L'Officiel and The Art Newspaper publish print editions in a total of nearly 28 countries and territories and digital contents. It operate in the movie production sector having produced various Asia-focused movies. It operate in three operating segments: media and entertainment segment, hotel operations, hospitality and VIP services segment and strategic investment segment. Key revenue is generated from strategic investment segment that is engage in proprietary investments and management of portfolio, including listed and unlisted equity shares investments and movie income right investments.

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

Share on Social Networks: